|
|
|
Insider
Information: |
Wilson Troy Edward |
Relationship: |
Director |
City: |
Los Angeles |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
93,642 |
|
Indirect Shares
|
974,552 |
|
|
Direct
Value |
$2,583,794 |
|
|
Indirect Value
|
$27,710,719 |
|
|
Total
Shares |
1,068,194 |
|
|
Total
Value |
$30,294,512 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-67.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Puma Biotechnology Inc |
PBYI |
Director |
2023-06-13 |
27,350 |
2023-06-13 |
550 |
Premium* |
|
Kura Oncology Inc |
KURA |
|
2024-01-24 |
559 |
2024-01-24 |
579,194 |
Premium* |
|
Zosano Pharma Corp |
ZSAN |
Director |
2015-04-01 |
3,000 |
2015-04-01 |
0 |
Premium* |
|
Avidity Biosciences, Inc. |
RNA |
Director |
2023-12-12 |
62,733 |
2023-12-12 |
394,808 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PBYI |
Puma Biotechnology Inc |
Director |
|
2013-10-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
350 |
|
- |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2013-10-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
550 |
|
- |
|
KURA |
Kura Oncology Inc |
President and CEOOfficer |
|
2015-03-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,168,727 |
|
- |
|
ZSAN |
Zosano Pharma Corp |
Director |
|
2015-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2016-12-05 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
1,735,991 |
0 |
- |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2017-04-21 |
4 |
OE |
$4.80 |
$24,000 |
D/D |
5,000 |
5,000 |
0 |
- |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2017-08-22 |
4 |
OE |
$4.80 |
$134,328 |
D/D |
27,985 |
32,985 |
0 |
- |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2018-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,822 |
6,172 |
0 |
- |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2018-11-06 |
4 |
OE |
$4.80 |
$124,997 |
D/D |
26,041 |
59,026 |
0 |
- |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2019-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
19,423 |
25,595 |
0 |
- |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2020-02-11 |
4 |
OE |
$4.80 |
$136,461 |
D/D |
28,096 |
54,137 |
0 |
- |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
25,748 |
51,343 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
189,618 |
|
- |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
711,067 |
|
- |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2020-06-11 |
4 |
S |
$9.97 |
$251,693 |
D/D |
(25,245) |
26,098 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
189,042 |
805,301 |
0 |
- |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2020-08-17 |
4 |
AS |
$22.00 |
$283,868 |
D/D |
(12,901) |
28,096 |
0 |
% |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2020-08-17 |
4 |
OE |
$4.80 |
$61,925 |
D/D |
12,901 |
40,997 |
0 |
- |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2020-08-17 |
4 |
AS |
$22.00 |
$1,100,000 |
I/I |
(50,000) |
356,736 |
0 |
% |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2020-08-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
26,041 |
1,795,017 |
0 |
- |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2020-08-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
26,041 |
28,096 |
0 |
- |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2020-08-18 |
4 |
OE |
$4.80 |
$2,501 |
D/D |
521 |
28,617 |
0 |
- |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2020-08-18 |
4 |
AS |
$22.00 |
$11,462 |
D/D |
(521) |
28,096 |
0 |
% |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2020-08-19 |
4 |
OE |
$4.80 |
$57,182 |
D/D |
11,913 |
40,009 |
0 |
- |
|
KURA |
Kura Oncology Inc |
President and CEO |
|
2020-08-19 |
4 |
AS |
$22.09 |
$263,196 |
D/D |
(11,913) |
28,096 |
0 |
% |
|
65 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|